CapyFin

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2025 CapyFin. All rights reserved.

Disclaimer: This platform provides information and recommendations for educational purposes only and is not a substitute for professional financial advice. Our content covers a range of investment classes, including stocks and cryptocurrencies, and we do not guarantee the completeness, accuracy, reliability, or suitability of this information, which may include data from third-party services and content generated by artificial intelligence (AI). Investing in stocks, cryptocurrencies, and other financial instruments involves risks, including the potential loss of principal. Users should independently verify all information and seek advice from qualified professionals tailored to their individual financial situations and investment objectives. Our content and services are provided "as is" without any warranties, express or implied. We are not liable for any losses or damages arising from the use of our services. This disclaimer is subject to change; users are advised to review it periodically. Usage of our services constitutes acceptance of these terms.

Applied Therapeutics

🇺🇸 NASDAQ:APLT

Overview Earnings Dividends

Mar 13, 2020

•

Dec 31, 2019

Applied Therapeutics Q4 2019 Earnings Report

Reported financial results for the fourth quarter and full year ended December 31, 2019.

Key Takeaways

Applied Therapeutics reported its Q4 and full-year 2019 financial results, highlighting a transformative year with progress in clinical development programs for Diabetic Cardiomyopathy and Galactosemia.

Transitioned to a public company.

Completed two additional financings.

Made significant progress in clinical development programs in Diabetic Cardiomyopathy and Galactosemia.

Plan to move quickly towards regulatory filing for Galactosemia and prepare for commercial launch.

EPS

-$1.57

Previous year: -$0.394

+298.4%

Gross Profit

$0

0

Applied Therapeutics

Applied Therapeutics

Forward Guidance

Applied Therapeutics plans to advance clinical programs and expand its pipeline in 2020.

Company Overview

Full financial data and analysis

View Applied Therapeutics